CD44 and neoplasm: We have previously found that recombinant CD44 HABD 21–132, as a model for soluble CD44, inhibited human subcutaneous tumor xenograft growth in mice, angiogenesis in chick chorio-allantoic membrane, and EC proliferation [27].